ReviewTherapeutic advances in respiratory disease

Cystic fibrosis: new challenges and perspectives beyond elexacaftor/tezacaftor/ivacaftor.

Vito Terlizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.